270 related articles for article (PubMed ID: 11696435)
1. Angiotensin-converting enzyme inhibition prevents glomerular-tubule disconnection and atrophy in passive Heymann nephritis, an effect not observed with a calcium antagonist.
Benigni A; Gagliardini E; Remuzzi A; Corna D; Remuzzi G
Am J Pathol; 2001 Nov; 159(5):1743-50. PubMed ID: 11696435
[TBL] [Abstract][Full Text] [Related]
2. Combining lisinopril and l-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis.
Zoja C; Benigni A; Camozzi D; Corna D; Longaretti L; Todeschini M; Remuzzi G
Kidney Int; 2003 Sep; 64(3):857-63. PubMed ID: 12911535
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II blockade limits tubular protein overreabsorption and the consequent upregulation of endothelin 1 gene in experimental membranous nephropathy.
Zoja C; Liu XH; Abbate M; Corna D; Schiffrin EL; Remuzzi G; Benigni A
Exp Nephrol; 1998; 6(2):121-31. PubMed ID: 9567218
[TBL] [Abstract][Full Text] [Related]
4. Effect of combining ACE inhibitor and statin in severe experimental nephropathy.
Zoja C; Corna D; Rottoli D; Cattaneo D; Zanchi C; Tomasoni S; Abbate M; Remuzzi G
Kidney Int; 2002 May; 61(5):1635-45. PubMed ID: 11967013
[TBL] [Abstract][Full Text] [Related]
5. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
[TBL] [Abstract][Full Text] [Related]
7. The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
Zoja C; Donadelli R; Corna D; Testa D; Facchinetti D; Maffi R; Luzzana E; Colosio V; Bertani T; Remuzzi G
Am J Kidney Dis; 1997 Feb; 29(2):254-64. PubMed ID: 9016898
[TBL] [Abstract][Full Text] [Related]
8. Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis.
Benigni A; Tomasoni S; Gagliardini E; Zoja C; Grunkemeyer JA; Kalluri R; Remuzzi G
J Am Soc Nephrol; 2001 May; 12(5):941-948. PubMed ID: 11316852
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibition prevents loss of glomerular hydraulic permeability in passive heymann nephritis.
Remuzzi A; Monaci N; Bonassi ME; Corna D; Zoja C; Mohammed EI; Remuzzi G
Lab Invest; 1999 Dec; 79(12):1501-10. PubMed ID: 10616201
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage.
Perico N; Amuchastegui CS; Malanchini B; Bertani T; Remuzzi G
Exp Nephrol; 1994; 2(4):220-8. PubMed ID: 8069658
[TBL] [Abstract][Full Text] [Related]
11. How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approach.
Zoja C; Corna D; Camozzi D; Cattaneo D; Rottoli D; Batani C; Zanchi C; Abbate M; Remuzzi G
J Am Soc Nephrol; 2002 Dec; 13(12):2898-908. PubMed ID: 12444208
[TBL] [Abstract][Full Text] [Related]
12. Effects of anti-proteinuric therapy with angiotensin-converting-enzyme inhibition on renal protein catabolism in the adriamycin-induced nephrotic rat.
Haas M; de Boer E; de Jong PE; Moolenaar F; Meijer DK; de Zeeuw D
Clin Sci (Lond); 2003 Jul; 105(1):51-7. PubMed ID: 12636872
[TBL] [Abstract][Full Text] [Related]
13. ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy.
Remuzzi A; Fassi A; Bertani T; Perico N; Remuzzi G
Am J Kidney Dis; 1999 Oct; 34(4):626-32. PubMed ID: 10516341
[TBL] [Abstract][Full Text] [Related]
14. Dissociation between antiproteinuric and antihypertensive effect of angiotensin converting enzyme inhibitors in rats.
Remuzzi A; Imberti O; Puntorieri S; Malanchini B; Macconi D; Magrini L; Bertani T; Remuzzi G
Am J Physiol; 1994 Dec; 267(6 Pt 2):F1034-44. PubMed ID: 7528985
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats.
Remuzzi A; Malanchini B; Battaglia C; Bertani T; Remuzzi G
Exp Nephrol; 1996; 4(1):19-25. PubMed ID: 8788596
[TBL] [Abstract][Full Text] [Related]
16. Sequence of events in the glomerular capillary wall at the onset of proteinuria in passive Heymann nephritis.
Fujigaki Y; Batsford S; Yamashita F; Yonemura K; Hishida A; Kawachi H; Shimizu F; Vogt A
Virchows Arch; 2001 Feb; 438(2):136-45. PubMed ID: 11253115
[TBL] [Abstract][Full Text] [Related]
17. Effect of angiotensin II antagonism on the regression of kidney disease in the rat.
Remuzzi A; Gagliardini E; Donadoni C; Fassi A; Sangalli F; Lepre MS; Remuzzi G; Benigni A
Kidney Int; 2002 Sep; 62(3):885-94. PubMed ID: 12164870
[TBL] [Abstract][Full Text] [Related]
18. Antiproteinuric therapy while preventing the abnormal protein traffic in proximal tubule abrogates protein- and complement-dependent interstitial inflammation in experimental renal disease.
Abbate M; Zoja C; Rottoli D; Corna D; Perico N; Bertani T; Remuzzi G
J Am Soc Nephrol; 1999 Apr; 10(4):804-13. PubMed ID: 10203365
[TBL] [Abstract][Full Text] [Related]
19. Calcium antagonist inhibits glomerular cell apoptosis and injuries of L-NAME exacerbated nephrosclerosis in SHR.
Watanabe S; Ono H; Ishimitsu T; Matsuoka H; Ono Y; Fujimori T
Hypertens Res; 2000 Nov; 23(6):683-91. PubMed ID: 11131282
[TBL] [Abstract][Full Text] [Related]
20. Comparison of converting enzyme inhibitor and calcium channel blocker in hypertensive glomerular injury.
Tolins JP; Raij L
Hypertension; 1990 Oct; 16(4):452-61. PubMed ID: 2210813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]